Outlook 2020: Regulatory Trends and Challenges
FREE ON-DEMAND WEBINAR
Outlook 2020: Regulatory trends and challenges
Recent manufacturing advances have led the FDA to proclaim that continuous manufacturing is one of the important tools to modernize the pharma industry through its faster, more efficient processes.
The move to continuous manufacturing involves more than just equipment and manufacturing processes. Regulatory compliance must also be considered. Get up to speed on the latest regulatory developments as we look forward to 2020. We’ll discuss key trends and changes in manufacturing that pharma companies should anticipate for a successful year.
To understand the future of continuous manufacturing in pharma, this presentation examines:
- Batch vs continuous processing
- The trends in adoption of continuous manufacturing
- Regulatory views of continuous manufacturing
- Navigating the implementation of continuous manufacturing in the current regulatory environment
* ~ * ~ *
About Clarivate: Clarivate is a global leader in providing solutions to accelerate the lifecycle of innovation. Its bold mission is to help customers solve some of the world’s most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. Clarivate helps customers discover, protect and commercialize their inventions using their trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit clarivate.com
In no way, I had an interest for writing articles. ...
FREE COURSE - FREE CERTIFICATE · FREE ONLINE COURS ...
You have no groups that fit your search